Pages that link to "Q2393348"
Jump to navigation
Jump to search
The following pages link to bimatoprost (Q2393348):
Displaying 50 items.
- glaucoma (Q159701) (← links)
- hypotrichosis (Q1641483) (← links)
- open-angle glaucoma (Q3108586) (← links)
- ocular hypertension (Q9294051) (← links)
- prostaglandin F receptor (Q21122493) (← links)
- (5Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((1E,3R)-3-hydroxy-5-phenyl-1-penten-1-yl)cyclopentyl)-N-ethyl-5-heptenamide (Q27281740) (← links)
- bimatoprost / timolol (Q28859628) (← links)
- Lumigan (Q29006146) (← links)
- Treatment of eyebrow hypotrichosis using bimatoprost: a randomized, double-blind, vehicle-controlled pilot study (Q45112758) (← links)
- Latisse (Q47521757) (← links)
- Therapeutic potential of bimatoprost for the treatment of eyebrow hypotrichosis (Q50348514) (← links)
- Intracameral Sustained-Release Bimatoprost Implant Delivers Bimatoprost to Target Tissues with Reduced Drug Exposure to Off-Target Tissues (Q58598925) (← links)
- Intraocular Pressure Effects and Mechanism of Action of Topical Versus Sustained-Release Bimatoprost (Q61806674) (← links)
- 24-hour Intraocular Pressure (IOP) Control With the Bimatoprost/Timolol Fixed Combination (Q61918420) (← links)
- Safety and Efficacy of Different Formulations of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension (Q61936175) (← links)
- Bimatoprost Versus Travoprost at Cairo University (Q61936957) (← links)
- Safety and Efficacy of Bimatoprost Timolol Ophthalmic Solution in Patients With Open Angle Glaucoma or Ocular Hypertension (Q61938980) (← links)
- Safety and Efficacy of Bimatoprost Ophthalmic Solution in Increasing Eyelash Prominence (Q61939428) (← links)
- Assessment of Intraocular Pressure (IOP) Control in Subjects With Open-Angle Glaucoma or Ocular Hypertension Treated With Travoprost 0.004% (TRAVATAN® Z) or Bimatoprost 0.01% (LUMIGAN®) (Q61956731) (← links)
- 24-Hour Intraocular Pressure Control With Bimatoprost/Timolol Versus Latanoprost as First Choice (Q61967694) (← links)
- Study Assessing Patient Satisfaction With LATISSE® for Increasing Eyelash Prominence (Q61967744) (← links)
- A Study of GANFORT® UD in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) in a Medical Setting (Q61969224) (← links)
- Intraocular Pressure and Tolerability Study of Preservative-free Prostaglandins (Bimatoprost and Latanoprost) on Glaucoma and Ocular Hypertension: European, Multicentric, Investigator-led, Single Masked Study (Q61974937) (← links)
- Bimatoprost as a Treatment for Graves' Orbitopathy (Q62042440) (← links)
- Bimatoprost 0.03% Solution With NB-UVB Versus Their Use With Fractional Carbon Dioxide Laser in Treatment of Generalized Vitiligo (Q62809097) (← links)
- Safety and Efficacy of LUMIGAN® RC Versus DuoTrav® in Patients Who Require Further Intraocular Pressure (IOP) Reduction (Q63316613) (← links)
- Observational Study of Lumigan® 0.01% for Treatment of Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) (Q63317802) (← links)
- A Safety and Efficacy Study of ALPHAGAN® P and LUMIGAN® in Subjects Previously Treated With Latanoprost for Glaucoma and Ocular Hypertension (Q63319022) (← links)
- Observational Study of Lumigan® 0.01% Treatment for Patients With Primary Open Angle Glaucoma or Ocular Hypertension (Q63321010) (← links)
- A Study of the Safety and Efficacy of Bimatoprost Ophthalmic Solution in Paediatric Patients With Glaucoma (Q63321214) (← links)
- Effects of Latanoprost, Bimatoprost and Travoprost in Patients With Latanoprost-resistant Glaucoma (Q63335018) (← links)
- Long-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension (Q63338623) (← links)
- Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension (Q63340158) (← links)
- Topical Bimatoprost in the Treatment of Migraine (Q63403826) (← links)
- Bimatoprost for the Treatment of Eyebrow Hypotrichosis (Q63571588) (← links)
- A Study of the Safety and Efficacy of Bimatoprost in Patients With Glaucoma or Ocular Hypertension (Q63571787) (← links)
- Comparing Safety and Efficacy of Combigan® and Lumigan® With Lumigan® Alone in Glaucoma or Ocular Hypertension Subjects Treated With Xalatan® (Q63572948) (← links)
- A Comparative Study of SPARC's SDP-133 Once Daily and Lumigan in Subjects With Open Angle Glaucoma or Ocular Hypertension (Q63577190) (← links)
- Long-term Safety and Efficacy Extension Trial of Bimatoprost SR (Q63580479) (← links)
- Evaluation of Hyperemia With the Use of Ocular Prostaglandin Analogues (Q63804915) (← links)
- Bimatoprost 0.03% Versus Travoprost 0.004% in Patients Currently on Latanoprost 0.005% (Q63804934) (← links)
- Dose-Response of Intracameral Bimatoprost Sustained-Release Implant and Topical Bimatoprost in Lowering Intraocular Pressure (Q64069725) (← links)
- Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension (2011-01-31) (Q86171310) (← links)
- Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension (2003-05-31) (Q86245553) (← links)
- A Study Evaluating the 24-Hour Intraocular Pressure Lowering Effect of Bimatoprost SR in Patients With Open-Angle Glaucoma or Ocular Hypertension (Q87930801) (← links)
- Mirtogenol and Bimatoprost on IOP in Hispanics With Open-Angle Glaucoma (Q93704529) (← links)
- AGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular Hypertension (Q105088780) (← links)
- 5-trans-17-phenyl trinor Prostaglandin F2alpha ethyl amide (Q106039035) (← links)
- Effect of Microneedling, Bimatoprost and Excimer in Vitiligo Treatment (Q113898357) (← links)
- Preservative-free Fixed-dose Combination of Tafluprost 0.0015% / Timolol 0.5% in Patients With Open-angle Glaucoma or Ocular Hypertension: Clinical Effectiveness, Tolerability and Safety in a Real World Setting (Q113909555) (← links)